Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

274
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

326
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
326
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

242
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
242
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Patient-centered Care01:13

Patient-centered Care

3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Applications of Logarithms01:28

Applications of Logarithms

278
Logarithmic functions are powerful tools for simplifying the mathematical representation of phenomena involving exponential changes. Their ability to convert multiplicative relationships into additive ones is especially valuable in various scientific and engineering contexts. One notable application of logarithms is measuring sound intensity, specifically through the decibel (dB) scale used in acoustics.Sound intensity levels vary over an extensive range, from the faintest audible whisper to...
278

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal PBPK model of midazolam and its metabolites for perinatal asphyxia and therapeutic hypothermia.

British journal of clinical pharmacology·2026
Same author

Pharmacogenetics in oncology: Unveiling its potential in treatment personalization and beyond.

Bulletin du cancer·2025
Same author

Bone sarcomas and cancer predisposition syndromes.

Bulletin du cancer·2025
Same author

DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy.

Cancer chemotherapy and pharmacology·2025
Same author

Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.

Neuro-oncology advances·2024
Same author

[SFCE harmonization workshops: Neonatal acute myeloid leukemia].

Bulletin du cancer·2024

Related Experiment Video

Updated: Feb 10, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.4K

Pharmacogenetics: Applications to Pediatric Patients.

Tiphaine Adam de Beaumais1, Evelyne Jacqz-Aigrain2

  • 1Department of Paediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France.

Advances in Pharmacology (San Diego, Calif.)
|May 27, 2018
PubMed
Summary

Individual genetic variations impact drug responses. This review explores developmental pharmacogenetics in children, highlighting how growth affects genotype-phenotype relationships and treatment outcomes compared to adults.

Keywords:
GeneticsPediatricsPharmacology

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.6K
Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

607

Related Experiment Videos

Last Updated: Feb 10, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.4K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.6K
Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

607

Area of Science:

  • Pharmacogenetics
  • Pediatric pharmacology
  • Genomic medicine

Background:

  • Individual genomic differences influence drug disposition and efficacy.
  • Biomarker identification is key for personalized drug dosage and treatment optimization.
  • Children exhibit unique developmental changes impacting drug response compared to adults.

Purpose of the Study:

  • To review developmental aspects of pharmacogenetics.
  • To provide practical examples of pharmacogenetic variations in pediatric populations.
  • To emphasize the importance of age-specific considerations in pharmacogenetics.

Main Methods:

  • Literature review of pharmacogenetic studies.
  • Analysis of developmental factors influencing drug response.
  • Case study examples illustrating genotype-phenotype correlations in children.

Main Results:

  • Genotype-phenotype relationships differ between pediatric and adult populations.
  • Developmental stages significantly alter drug metabolism and response.
  • Pharmacogenetic principles require adaptation for pediatric treatment.

Conclusions:

  • Understanding developmental pharmacogenetics is crucial for optimizing pediatric drug therapy.
  • Personalized medicine in children necessitates consideration of growth and maturation.
  • Further research is needed to establish comprehensive pediatric pharmacogenetic guidelines.